EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA
Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for tough lung cancers
Disease control CompletedThis study tested a combination of two drugs, auranofin and sirolimus, in 29 people with advanced or recurrent lung cancer who had run out of standard treatment options. The goal was to find the best dose and see if the combo could slow cancer growth. The trial focused on safety …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Immune booster plus radiation shows promise against tough lung cancer
Disease control CompletedThis early-phase study tested adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation for people with small cell lung cancer. The goal was to find the safest dose and see if the combination helps control the cancer. 83 patients took part, and researcher…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Can brain radiation be smarter? new study tests Memory-Sparing approach
Symptom relief CompletedThis study looked at two types of brain radiation for people with small cell lung cancer that had spread. One method treated the whole brain, while the other tried to avoid the memory center (hippocampus) to reduce thinking and memory side effects. The trial enrolled 418 patients…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC